We are live on ! Find out more
SGAR

iPath Pure Beta Sugar ETN
SGAR

Delisted

SGAR was delisted on the 11th of April, 2018.

Back to rankings

1 hedge funds and large institutions have $53K invested in iPath Pure Beta Sugar ETN in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more capital invested

Capital invested by funds: $31K → $53K (+$22K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$18.9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$53K +$18.9K +819 +62%

SGAR Hedge Fund Activity: Q1 2016 in Review

1 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q1 2016, worth a combined $53K — up 71% from $31K a quarter earlier.

Fund positioning in SGAR was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $18.9K.

  • 1 institutional investor held iPath Pure Beta Sugar ETN (SGAR) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $53K of iPath Pure Beta Sugar ETN stock for Q1 2016, up 71% quarter-over-quarter.
  • 0 funds opened new iPath Pure Beta Sugar ETN positions in Q1 2016 and 0 closed out.
  • The largest iPath Pure Beta Sugar ETN buyer in Q1 2016 was UBS Group, an estimated $18.9K added.

Based on aggregated 13F filings for Q1 2016.